Prenatal exposure to antiepileptic drugs

Lancet

Volumn 367, Issue 9521, 2006, Pages 1467-1469

  Perucca, Emilio ^a,b   Tomson, Torbjorn ^c  

^a UNIVERSITY OF PAVIA   (Italy)

^b San Matteo Medical Center   (Italy)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENYTOIN; TERATOGENIC AGENT; THALIDOMIDE; VALPROIC ACID;

ANTICONVULSANT ACTIVITY; ARTICLE; CONGENITAL MALFORMATION; CORRELATION ANALYSIS; EMBRYOPATHY; EPILEPSY; FACE DYSMORPHIA; GROWTH RETARDATION; HUMAN; HYPOPLASIA; INTELLIGENCE QUOTIENT; MICROCEPHALY; PHENOTYPE; PREDICTION; PRENATAL EXPOSURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 33646174306     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)68627-3     Document Type: Note

References (15)

1. Lombroso C. L'uomo delinquente. 6th edn. (1897), Flli. Bocca Editori, Turin
2. Kini U., Adab N., Vinten J., and on behalf of the Liverpool and Manchester Neurodevelopmental Study Group. Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes. Arch Dis Child Fetal Neonatal Ed 91 (2006) F90-F95
3. Holmes L., Harvey E., Coull B., et al. The teratogenicity of anticonvulsant drugs. N Engl J Med 344 (2001) 1132-1138
4. Dean J., Hailey H., Moore S., et al. Long-term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet 39 (2002) 251-259
5. Moore S., Turnpenny P., Quinn A., et al. A clinical study of 57 children with fetal anticonvulsant sindrome. J Med Genet 37 (2000) 489-497
6. Adam J., Vorhee C., and Middaugh L. Developmental toxicity of anticonvulsants: human and animal evidence on phenytoin. Neurotoxicol Teratol 12 (1990) 203-214
7. Jones K., Lacro R., Johnson K., and Adams J. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 320 (1989) 1480-1481
8. Ardinger H., Atkin J., Blackston R., et al. Verification of the fetal valproate syndrome phenotype. Am J Med Genet 29 (1988) 171-185
9. Perucca E. Birth defects after prenatal exposure to antiepilepic drugs. Lancet Neurol 4 (2005) 781-786
10. Morrow J., Russell A., Guthrie E., et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psych 77 (2006) 193-198
11. Holmes L. The teratogenicity of anticonvulsant drugs: a progress report. J Med Genet 39 (2002) 245-247
12. Gaily E., Kantola-Sorsa E., Hilesmaa V., et al. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 62 (2004) 28-32
13. Vinten J., Adab N., Kini U., et al. Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology 64 (2005) 949-954
14. Adab N., Jacoby A., Smith D., Williamson P., and Winterbottom J. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 70 (2001) 15-21
15. Eriksson K., Viinikainen K., Monkkonen A., et al. Children exposed to valproate in utero: population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Res 65 (2005) 189-200